Solithromycin (CEM-101): A New Fluoroketolide Antibiotic and Its Role in the Treatment of Gonorrhea.

about

Solithromycin (CEM-101): A New Fluoroketolide Antibiotic and Its Role in the Treatment of Gonorrhea.

Item

http://www.wikidata.org/entity/Q38793951

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Solithromycin (CEM-101): A New ...... in the Treatment of Gonorrhea.

@en

type

Item

label

Solithromycin (CEM-101): A New ...... in the Treatment of Gonorrhea.

@en

prefLabel

Solithromycin (CEM-101): A New ...... in the Treatment of Gonorrhea.

@en

P1476

Solithromycin (CEM-101): A New ...... in the Treatment of Gonorrhea.

@en

P2093

Alexandra M Mancuso

http://www.w3.org/2001/XMLSchema#string

Judianne Slish

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors

Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis

In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.

In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.

CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.

Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci.

Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.

Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment

In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatm

P304

195-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0897190017708073

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mona A Gandhi

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28490220

http://www.w3.org/2001/XMLSchema#string

P921

antibiotic